Abstract
Rationale: Unacylated ghrelin (UnAG) is an emerging modulator of skeletal muscle metabolic pathways with reported anti-oxidative, anti-inflammatory and insulin-sensitizing actions in rodent healthy and disease models. In chronic disease experimental conditions, sustained UnAG administration was reported to normalize low muscle mass. Potential associations between UnAG and muscle mass in humans remain however undefined.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
